VOYA Investment Management
PLX icon

VOYA Investment Management’s Protalix BioTherapeutics PLX Stock Holding History

VOYA Investment Management’s Portfolio PLX Stock Details PLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24.9K Buy
+11,494
New +$28.5K ﹤0.01% 2326
2024
Q2 		– Sell
-27,023
Closed -$34K – 2889
2024
Q1 		$34K Sell
27,023
-2,242
-8% -$3.35K ﹤0.01% 2757
2023
Q4 		$52.1K Hold
29,265
– – ﹤0.01% 2846
2023
Q3 		$48.6K Buy
29,265
+5,386
+23% +$9.67K ﹤0.01% 2856
2023
Q2 		$47.8K Buy
+23,879
New +$56.9K ﹤0.01% 2904

Other funds holding PLX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SWP
Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

VOYA Investment Management's PLX Position: Q1 2026 in Review

VOYA Investment Management opened a new position in Protalix BioTherapeutics (PLX) in Q1 2026: 11,494 shares worth $24.9K. The stake represents ﹤0.01% of the portfolio and ranks #2326 among its holdings. This is a return to the name: VOYA Investment Management previously reported a position in PLX as recently as Q1 2024.

VOYA Investment Management first reported a position in PLX in Q2 2023 and has held it in 5 quarters since. The position peaked at $52.1K in Q4 2023. 99 funds tracked by Wall St. Rank hold PLX as of Q1 2026.

  • VOYA Investment Management held 11,494 shares of Protalix BioTherapeutics worth $24.9K as of Q1 2026.
  • Protalix BioTherapeutics was a new VOYA Investment Management position in Q1 2026.
  • Protalix BioTherapeutics made up ﹤0.01% of VOYA Investment Management's portfolio in Q1 2026, its #2326 holding.
  • VOYA Investment Management first reported a position in Protalix BioTherapeutics in Q2 2023 and has held it in 5 quarters since.
  • VOYA Investment Management's Protalix BioTherapeutics position peaked at $52.1K in Q4 2023.
  • 99 funds tracked by Wall St. Rank held Protalix BioTherapeutics as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.